Bortez

1 mg

2 mg

Brand Name: Bortez
Generic Name: Bortezomib for Injection
Strengths Available: 1 mg, 2 mg
Dosage Form: Lyophilized Powder for Injection
Route of Administration: Intravenous (IV) or Subcutaneous (SC) use

---

Description:

Bortez Injection contains Bortezomib, a proteasome inhibitor used in cancer chemotherapy. Bortezomib acts by inhibiting the 26S proteasome, a complex that plays a critical role in degrading ubiquitinated proteins, ultimately leading to cancer cell apoptosis.

---

Indications:

• Multiple Myeloma

• Mantle Cell Lymphoma (MCL)

• Other indications as approved by medical guidelines

---

Composition:

Each vial contains:

• Bortezomib 1 mg or 2 mg (as a lyophilized powder)

• Excipients: Mannitol and others (q.s.)

---

Appearance:

• Lyophilized white to off-white powder in a single-use vial.

---

Reconstitution:

Reconstituted with sterile 0.9% Sodium Chloride Injection before administration.
Administer via IV push or SC injection as per the recommended protocol.

---

Storage:

• Store below 25°C. Protect from light.

• Use the reconstituted solution immediately or within the specified time frame per guidelines.

---

Packaging:

• Single vial of 1 mg or 2 mg in a carton with a package insert.